<DOC>
	<DOC>NCT02868385</DOC>
	<brief_summary>An open label, randomized controlled trial of single vs. multiple treatments of praziquantel in intestinal African schistosomiasis in Côte d'Ivoire This study aims to determine the efficacy of repeated (up to four times) praziquantel treatment against S. mansoni infection in school-age children from Côte d'Ivoire using the traditional Kato-Katz thick smear technique, but also with more accurate and non-invasive antigen- and DNA-detection methods.</brief_summary>
	<brief_title>Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)</brief_title>
	<detailed_description />
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Subject has a confirmed S. mansoni infection (positive POCCCA test result and at least one positive out of triplicate KatoKatz thick smears) Subject is aged between 5 and 18 years and otherwise in good health Subject has received no recent praziquantel treatment in the past 12 months Subject has provided oral assent and provided written informed consent signed by parents/legal guardian Subject is able and willing to provide multiple stool and urine samples during study Known allergy to study medication (i.e. praziquantel and albendazole) Pregnancy Lactating</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Schistosomiasis</keyword>
	<keyword>Schistosoma mansoni</keyword>
	<keyword>Bilharzia</keyword>
</DOC>